blaVIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States

被引：114

作者：

Toleman, MA ^{[1
]}

Rolston, K

Jones, RN

Walsh, TR

机构：

[1] Univ Bristol, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England

[2] Anderson Med Ctr, Houston, TX USA

[3] JMI Labs, JONES Grp, N Liberty, IA USA

[4] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 01期

关键词：

D O I：

10.1128/AAC.48.1.329-332.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

As part of the CANCER Antimicrobial Surveillance Program in North America, a Pseudomonas aeruginosa isolate, strain 07-406, was shown to possess a metallo-beta-lactamase, designated VIM-7. bla(VIM-7) is located on a 24-kb plasmid which can be readily transferred into Enterobacteriaceae and other pseudomonads. This is the first report of a mobile metallo-beta-lactamase gene, bla(VIM-7), being detected within the United States.

引用

页码：329 / 332

页数：4

共 15 条

[1] INVITRO EVALUATION OF BRL 42715, A NOVEL BETA-LACTAMASE INHIBITOR
COLEMAN, K
GRIFFIN, DRJ
PAGE, JWJ
UPSHON, PA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (09) : 1580 - 1587
[2] Antibiotic resistance in gram-negative bacteria: the role of gene cassettes and integrons
Hall, RM
Collis, CM
[J]. DRUG RESISTANCE UPDATES, 1998, 1 (02) : 109 - 119
[3] Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes
Laraki, N
Galleni, M
Thamm, I
Riccio, ML
Amicosante, G
Frère, JM
Rossolini, GM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (04) : 890 - 901
[4] Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
Lauretti, L
Riccio, ML
Mazzariol, A
Cornaglia, G
Amicosante, G
Fontana, R
Rossolini, GM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (07) : 1584 - 1590
[5] Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece
Mavroidi, A
Tsakris, A
Tzelepi, E
Pournaras, S
Loukova, V
Tzouvelekis, LS
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (06) : 1041 - 1043
[6] Escherichia coli with a self-transferable, multiresistant plasmid coding for metallo-β-lactamase VIM-1
Miriagou, V
Tzelepi, E
Gianneli, D
Tzouvelekis, LS
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 395 - 397
[7] Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France
Poirel, L
Naas, T
Nicolas, D
Collet, L
Bellais, S
Cavallo, JD
Nordmann, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (04) : 891 - 897
[8] Novel variant (blaVlM-4) of the metallo-β-lactamase gene blaVIM-1 in a clinical strain of Pseudomonas aeruginosa
Pournaras, S
Tsakris, A
Maniati, M
Tzouvelekis, LS
Maniatis, AN
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) : 4026 - 4028
[9] Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America:: report from the SENTRY antimicrobial surveillance programme
Toleman, MA
Simm, AM
Murphy, TA
Gales, AC
Biedenbach, DJ
Jones, RN
Walsh, TR
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (05) : 673 - 679
[10] Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece
Tsakris, A
Pournaras, S
Woodford, N
Palepou, AFI
Babini, GS
Douboyas, J
Livermore, DM
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) : 1290 - 1292

← 1 2 →